Related references
Note: Only part of the references are listed.Pentacyclic Triterpenoids-Based Ionic Compounds: Synthesis, Study of Structure-Antitumor Activity Relationship, Effects on Mitochondria and Activation of Signaling Pathways of Proliferation, Genome Reparation and Early Apoptosis
Lilya U. Dzhemileva et al.
CANCERS (2023)
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells
Isabella Giacomini et al.
CANCERS (2023)
The Molecular Mechanisms of Oleanane Aldehyde-β-enone Cytotoxicity against Doxorubicin-Resistant Cancer Cells
Natalia Moiseeva et al.
BIOLOGY-BASEL (2023)
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
Alessia Catalano et al.
MOLECULES (2022)
Lupane Triterpene Derivatives Improve Antiproliferative Effect on Leukemia Cells through Apoptosis Induction
Lia S. Valencia-Chan et al.
MOLECULES (2022)
Semisynthetic Derivatives of Pentacyclic Triterpenes Bearing Heterocyclic Moieties with Therapeutic Potential
Gabriela Nistor et al.
MOLECULES (2022)
Betulinic acid in the treatment of tumour diseases: Application and research progress
Wenkai Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Plant extracts and betulin from Ligaria cuneifolia inhibit P-glycoprotein function in leukemia cells
Jeronimo Laiolo et al.
FOOD AND CHEMICAL TOXICOLOGY (2021)
Triterpenoids with modified A-ring as modulators of P-gp-dependent drug-resistance in cancer cells
Ekaterina Yu Rybalkina et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Anticancer Potential of Betulonic Acid Derivatives
Adelina Lombrea et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Comparative in silico prediction of P-glycoprotein-mediated transport for 2010-2020 US FDA-approved drugs using six Web-tools
Nelly Gueniche et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2021)
Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites
Mahmoud Zaki El-Readi et al.
FRONTIERS IN PHARMACOLOGY (2021)
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong et al.
DRUG RESISTANCE UPDATES (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Effect of betulin and betulonic acid on isolated rat liver mitochondria and liposomes
Mikhail Dubinin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2020)
Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators
Bruno M. F. Goncalves et al.
MOLECULES (2020)
Mitochondrial targeted strategies and their application for cancer and other diseases treatment
Qiuyi Li et al.
JOURNAL OF PHARMACEUTICAL INVESTIGATION (2020)
PgpRules: a decision tree based prediction server for P-glycoprotein substrates and inhibitors (vol 35, pg 4535, 2019)
Pei-Hua Wang et al.
BIOINFORMATICS (2019)
Synthetic modification and cytotoxic evaluation of 2-cyano-3,4-secotriterpenic methylketones
Alexey V. Nazarov et al.
CHEMICAL PAPERS (2019)
Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR)
Mohamed E. M. Saeed et al.
FRONTIERS IN PHARMACOLOGY (2018)
An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein
Xiaoqian Yang et al.
CURRENT CANCER DRUG TARGETS (2018)
Triple Fluorescence staining to Evaluate Mechanism-based Apoptosis following Chemotherapeutic and Targeted Anti-cancer Drugs in Live Tumor Cells
Pradip De et al.
SCIENTIFIC REPORTS (2018)
The Effects of Synthetically Modified Natural Compounds on ABC Transporters
Daniel Dantzic et al.
PHARMACEUTICS (2018)
Synthesis, cytotoxic evaluation, and molecular docking studies of the semi-synthetic triterpenoid-steroid hybrids
Irina A. Tolmacheva et al.
STEROIDS (2018)
Toward a Better Understanding of the Complexity of Cancer Drug Resistance
Michael M. Gottesman et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay
Elodie Jouan et al.
PHARMACEUTICS (2016)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Betulinic Acid and its Derivatives as Potential Antitumor Agents
Dong-Mei Zhang et al.
MEDICINAL RESEARCH REVIEWS (2015)
New derivatives of lupane triterpenoids disturb breast cancer mitochondria and induce cell death
Teresa L. Serafim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Functionalization, cyclization and antiviral activity of A-secotriterpenoids
Victoria V. Grishko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Betulinic acid and its derivatives: a patent review (2008-2013)
Rene Csuk
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells
Dong-Mei Zhang et al.
ANTI-CANCER DRUGS (2013)
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
Matthew Brentnall et al.
BMC CELL BIOLOGY (2013)
BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo
Dong-Mei Zhang et al.
MOLECULAR PHARMACEUTICS (2012)
Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells
Guozhu Chen et al.
BMC CANCER (2011)
Triterpenes part 114 - Preparation and conformational study of B-ring substituted lupane derivatives
Martin Dracinsky et al.
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2006)
Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors
RB Wang et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2003)
Share Paper
